Appendicitis and multiple sclerosis disease-modifying therapies: a disproportionality analysis of the FDA adverse event reporting system. - Balshi A; Esser M; Dempsey JP; Baber U; Sloane JA (Multiple sclerosis and related disorders, 2026)